Characterization of adrenal pheochromocytoma using respiratory-triggered proton MR spectroscopy: Initial experience

American Journal of Roentgenology

Volumn 192, Issue 2, 2009, Pages 450-454

  Kim, Sooah ^b   Salibi, Nouha ^a,c   Hardie, Andrew D ^b,d   Xu, Jian ^a,c   Lim, Ruth P ^b   Lee, Vivian S ^b   Taouli, Bachir ^b  

^a SIEMENS AG   (Germany)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c SIEMENS CORPORATE RESEARCH   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adenoma; Adrenal gland neoplasms; Catecholamine; MR spectroscopy; Pheochromocytoma

Indexed keywords

ADRENALIN; DOPAMINE; METADRENALIN; NORADRENALIN; NORMETADRENALIN;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ARTICLE; BREATHING; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTRUM;

ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; AGED; CATECHOLAMINES; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; PROSPECTIVE STUDIES; PROTONS; RESPIRATION;

EID: 59349083339     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.4027     Document Type: Article

References (13)

1. Leroy-Willig A, Bittoun J, Luton JP, et al. In vivo MR spectroscopic imaging of the adrenal glands: distinction between adenomas and carcinomas larger than 15 mm based on lipid content. AJR 1989; 153:771-773
2. Faria JF, Goldman SM, Szejnfeld J, et al. Adrenal masses: characterization with in vivo proton MR spectroscopy - initial experience. Radiology 2007; 245:788-797
3. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 1997; 37:222-225
4. 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration. Invest Radiol 2005; 40:405-411
5. Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 2004; 56:331-349
6. Wishart D. Human metabolome database. Metabolomics Toolbox Website. www.hmdb.ca. Accessed December 9, 2008
7. Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995; 5:281-285
8. Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992; 185:345-351
9. Bilbey JH, McLoughlin RF, Kurkjian PS, et al. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. AJR 1995; 164:637-642
10. Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J, et al. 1,111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors. Ann N Y Acad Sci 2006; 1073:38-46
11. Varghese JC, Hahn PF, Papanicolaou N, Mayo-Smith WW, Gaa JA, Lee MJ. MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times. Clin Radiol 1997; 52:603-606
12. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002; 287:1427-1434
13. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984; 153:189-194